Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) A Strong Dividend Stock?

A large part of investment returns can be generated by dividend-paying stock given their role in compounding returns over time. Historically, Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) has paid a dividend to shareholders. It currently yields 1.4%. Does Fisher & Paykel Healthcare tick all the boxes of a great dividend stock? Below, I’ll take you through my analysis.

View our latest analysis for Fisher & Paykel Healthcare

5 checks you should do on a dividend stock

When researching a dividend stock, I always follow the following screening criteria:

  • Is their annual yield among the top 25% of dividend payers?
  • Has it consistently paid a stable dividend without missing a payment or drastically cutting payout?
  • Has dividend per share amount increased over the past?
  • Is is able to pay the current rate of dividends from its earnings?
  • Will it be able to continue to payout at the current rate in the future?
NZSE:FPH Historical Dividend Yield, March 3rd 2019
NZSE:FPH Historical Dividend Yield, March 3rd 2019

How well does Fisher & Paykel Healthcare fit our criteria?

The current trailing twelve-month payout ratio for the stock is 62%, meaning the dividend is sufficiently covered by earnings. Going forward, analysts expect FPH’s payout to increase to 78% of its earnings. Assuming a constant share price, this equates to a dividend yield of around 2.1%. Furthermore, EPS should increase to NZ$0.40. The higher payout forecasted, along with higher earnings, should lead to greater dividend income for investors moving forward.

If you want to dive deeper into the sustainability of a certain payout ratio, you may wish to consider the cash flow of the business. A company with strong cash flow, relative to earnings, can sometimes sustain a high pay out ratio.

If there’s one type of stock you want to be reliable, it’s dividend stocks and their stable income-generating ability. Not only have dividend payouts from Fisher & Paykel Healthcare fallen over the past 10 years, it has also been highly volatile during this time, with drops of over 25% in some years. These characteristics do not bode well for income investors seeking reliable stream of dividends.

In terms of its peers, Fisher & Paykel Healthcare has a yield of 1.4%, which is high for Medical Equipment stocks but still below the low risk savings rate.

Next Steps:

After digging a little deeper into Fisher & Paykel Healthcare’s yield, it’s easy to see why you should be cautious investing in the company just for the dividend. On the other hand, if you are not strictly just a dividend investor, the stock could still be offering some interesting investment opportunities. Given that this is purely a dividend analysis, I recommend taking sufficient time to understand its core business and determine whether the company and its investment properties suit your overall goals. There are three essential factors you should look at:

  1. Future Outlook: What are well-informed industry analysts predicting for FPH’s future growth? Take a look at our free research report of analyst consensus for FPH’s outlook.
  2. Valuation: What is FPH worth today? Even if the stock is a cash cow, it’s not worth an infinite price. The intrinsic value infographic in our free research report helps visualize whether FPH is currently mispriced by the market.
  3. Dividend Rockstars: Are there better dividend payers with stronger fundamentals out there? Check out our free list of these great stocks here.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.